With respect to the often-observed coincidence of obesity and depression in humans and the frequent use of SSRI in this population, interrelations of altered SERT function and metabolic and/or cardiovascular consequences of obesity are of major interest (25–27). Here, SLC6A4 is linked to obesity due to melanocortin 4 receptor deficiency.